147 related articles for article (PubMed ID: 13798373)
1. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
[No Abstract] [Full Text] [Related]
2. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
[No Abstract] [Full Text] [Related]
3. [Effect of nor-androstenolone phenylpropionate (Durabolin) on weight increase in atrophic children].
UJSAGHY P
Gyermekgyogyaszat; 1962 Jul; 13():210-8. PubMed ID: 13923627
[No Abstract] [Full Text] [Related]
4. Failure of 19-nor-androstenolone phenylpropionate (durabolin) to prevent the alterations produced by cortisone on the growing bone in rats.
LARON Z; BOSS JH
Endocrinology; 1961 Sep; 69():608-12. PubMed ID: 13759150
[No Abstract] [Full Text] [Related]
5. Nandrolone-phenpropionate in progressive muscular dystrophy.
BROWN IA; JAMES EM
Arch Pediatr (N Y); 1961 Nov; 78():421-31. PubMed ID: 13873658
[No Abstract] [Full Text] [Related]
6. A study of the treatment of dystrophia musculorum progressiva with an anabolic steroid: nor-androstenolone decanoate.
PATEISKY K; SCHINKO H; HABERLER H
Acta Endocrinol Suppl (Copenh); 1961; 39(Suppl 63)():185-98. PubMed ID: 14484294
[No Abstract] [Full Text] [Related]
7. [Anabolic and metabolic effects during nor-androstenolone phenylpropionate (NAPP) therapy].
DEMOLE R; THIERY M; FRANCOIS-TERMONT E; BEKAERT J; PEETERS H; VUYLSTEKE P
Praxis; 1960 May; 49():477-86. PubMed ID: 13815860
[No Abstract] [Full Text] [Related]
8. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
MALMIO K; HISI-BRUMMER L; HORTLING H
Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
[No Abstract] [Full Text] [Related]
9. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
BARTA ; CSERE M; NABRADY J
Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
[No Abstract] [Full Text] [Related]
10. [ACTION OF 19-NOR-ANDROSTENOLONE PHENYLPROPIONATE ON THE RECOVERY OF PANIRRADIATED ANIMALS].
CAPRINO G; GALLINA F
Boll Soc Ital Biol Sper; 1963 Dec; 39():1687-91. PubMed ID: 14124843
[No Abstract] [Full Text] [Related]
11. [Nor-androstenolone phenylpropionate (N.A.P.P) as an adjuvant in the treatment of marasmus].
CORTES MARTINEZ A
Arch Col Med El Salv; 1961 Sep; 14():131-44. PubMed ID: 13881499
[No Abstract] [Full Text] [Related]
12. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
ZARA M; LUMBROSO A
Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
[No Abstract] [Full Text] [Related]
13. [Use of nor-androstenolone phenylpropionate in premature infants of the Congo].
HUGON J
Brux Med; 1959 May; 39(18):627-33. PubMed ID: 13651796
[No Abstract] [Full Text] [Related]
14. [Clinical use of norandrostenolone phenylpropionate].
VAN OS H; DEMEULEMEESTER J
Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
[No Abstract] [Full Text] [Related]
15. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
de SALCEDO ; BORGES F; GODINHO P
J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
[No Abstract] [Full Text] [Related]
16. [Progressive muscular dystrophy treated with Durabolin].
WORM J
Ugeskr Laeger; 1962 Sep; 124():1325-7. PubMed ID: 14001882
[No Abstract] [Full Text] [Related]
17. The haemopoietic effect of nandrolone-phenylpropionate (Durabolin).
BOOIJ J; KUYPERS J
Acta Physiol Pharmacol Neerl; 1962; 11():12-9. PubMed ID: 13871124
[No Abstract] [Full Text] [Related]
18. [Importance of norandrostenolone phenylpropionate in psychiatric therapy].
BOITTELLE G; BOITTELLE-LENTULO C; DUMEZIL C
Ann Med Psychol (Paris); 1962 Feb; 120(1)():389-92. PubMed ID: 13870704
[No Abstract] [Full Text] [Related]
19. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
MARKKANEN T
Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
[No Abstract] [Full Text] [Related]
20. [Preliminary clinical trials with the phenylpropionate of norandrostenolone (PPNA) as a protein anabolizing agent].
HUGUENARD P; GODARD H
Therapie; 1959; 14():738-44. PubMed ID: 14403896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
